NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,921,266 | +4.3% | 4,904,745 | +0.7% | 0.02% | +6.2% |
| Q2 2023 | $2,801,499 | +52.2% | 4,870,478 | +86.0% | 0.02% | +45.5% |
| Q1 2023 | $1,840,253 | -68.3% | 2,618,087 | +1.8% | 0.01% | -71.8% |
| Q4 2022 | $5,810,119 | +75.0% | 2,570,849 | +147.7% | 0.04% | +50.0% |
| Q3 2022 | $3,321,000 | +283.5% | 1,037,929 | +355.3% | 0.03% | +271.4% |
| Q2 2022 | $866,000 | -31.0% | 227,963 | +145.3% | 0.01% | -12.5% |
| Q4 2021 | $1,255,000 | -19.8% | 92,917 | +6.7% | 0.01% | -27.3% |
| Q3 2021 | $1,564,000 | +257.9% | 87,082 | +241.8% | 0.01% | +266.7% |
| Q2 2021 | $437,000 | +11.5% | 25,481 | +30.0% | 0.00% | 0.0% |
| Q1 2021 | $392,000 | -69.4% | 19,607 | -74.0% | 0.00% | -72.7% |
| Q4 2020 | $1,283,000 | +0.7% | 75,476 | -1.7% | 0.01% | -15.4% |
| Q3 2020 | $1,274,000 | -6.0% | 76,781 | +31.2% | 0.01% | -13.3% |
| Q2 2020 | $1,355,000 | +731.3% | 58,525 | +392.6% | 0.02% | +400.0% |
| Q1 2016 | $163,000 | -95.3% | 11,880 | -95.7% | 0.00% | -95.5% |
| Q2 2015 | $3,487,000 | +197.0% | 278,740 | +161.1% | 0.07% | +230.0% |
| Q1 2015 | $1,174,000 | -84.5% | 106,750 | -78.2% | 0.02% | -84.6% |
| Q4 2014 | $7,585,000 | +73.7% | 489,386 | +35.3% | 0.13% | +78.1% |
| Q3 2014 | $4,367,000 | +16.1% | 361,786 | +23.3% | 0.07% | +17.7% |
| Q2 2014 | $3,761,000 | +293.4% | 293,386 | +248.4% | 0.06% | +342.9% |
| Q4 2013 | $956,000 | -11.5% | 84,210 | -18.5% | 0.01% | -22.2% |
| Q3 2013 | $1,080,000 | – | 103,380 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |